V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002819 | 330001519 | 1.61 | 58.7 | Neo-adjuvant (N) | 2018-05-14 | 2018-05-14 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330011546 | CARBOPLATIN + PACLITAXEL |
| 330002820 | 330006805 | 1.53 | 78.6 | Palliative (P) | 2017-07-20 | 2017-05-02 | CARBOPLATIN + PACLITAXEL | 2 | N | 330011549 | CARBOPLATIN + PACLITAXEL |
| 330002821 | 330006805 | 1.58 | 104 | Curative (C) | 2017-05-17 | 2017-05-23 | Rituximab | N | N | 330011549 | RITUXIMAB |
| 330002822 | 330006805 | null | 68.3 | Adjuvant (A) | 2015-01-07 | 2015-01-07 | Bendamustine+Rituximab (1st Course) | 02 | N | 330011549 | BENDAMUSTINE + RITUXIMAB |
| 330002823 | 330001520 | 1.93 | 88.6 | null | 2014-08-19 | 2014-10-15 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330011558 | BENDAMUSTINE + RITUXIMAB |
| 330002824 | 330001520 | 1.63 | 86.4 | Palliative (P) | 2017-12-28 | 2018-01-07 | CARBOPLATIN + PACLITAXEL | N | null | 330011558 | CARBOPLATIN + PACLITAXEL |
| 330002825 | 330001521 | 1.69 | 78.6 | Not known (9) | 2013-07-17 | 2013-07-17 | Liposomal Doxorubicin (20mg/m2) | 2 | N | 330011561 | LIPOSOMAL DOXORUBICIN |
| 330002826 | 330001521 | 1.7 | 53.9 | Palliative (P) | 2014-09-12 | 2014-09-21 | Carboplatin + Etoposide iv&po | null | null | 330011561 | CARBOPLATIN + ETOPOSIDE |
| 330002827 | 330001522 | 1.8 | 79.1 | Curative (C) | 2017-04-15 | 2017-04-10 | Carboplatin + Etoposide iv&po | 02 | N | 330011564 | CARBOPLATIN + ETOPOSIDE |
| 330002828 | 330001523 | 1.55 | 58.2 | Palliative (P) | 2018-02-22 | 2018-02-22 | Rituximab (Maintenance) | N | N | 330011568 | RITUXIMAB |
| 330002829 | 330001523 | 1.8 | 64 | null | 2017-01-05 | 2017-01-05 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011568 | CARBOPLATIN + PACLITAXEL |
| 330002830 | 330001524 | 1.6 | null | Palliative (P) | 2013-10-23 | 2013-10-28 | Cisplatin + Doxorubicin | N | N | 330011578 | CISPLATIN + DOXORUBICIN |
| 330002831 | 330001525 | 1.67 | 77.1 | Palliative (P) | 2013-11-28 | 2013-11-29 | Liposomal Doxorubicin (20mg/m2) | 02 | N | 330011580 | LIPOSOMAL DOXORUBICIN |
| 330002832 | 330006809 | 1.64 | 65.2 | null | 2015-10-24 | 2015-10-25 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330011584 | LIPOSOMAL DOXORUBICIN |
| 330002833 | 330001526 | 1.77 | 87.2 | null | 2014-01-30 | 2014-02-06 | Cisplatin + Doxorubicin | N | N | 330011590 | CISPLATIN + DOXORUBICIN |
| 330002834 | 330001527 | 1.69 | 79.3 | Palliative (P) | 2017-02-25 | 2017-02-27 | Cisplatin + Doxorubicin | N | N | 330011594 | CISPLATIN + DOXORUBICIN |
| 330002835 | 330001527 | 1.79 | 84 | Palliative (P) | 2014-03-07 | 2014-03-13 | Carboplatin + Paclitaxel (3 weekly) | null | null | 330011594 | CARBOPLATIN + PACLITAXEL |
| 330002836 | 330001527 | 1.57 | null | Disease modification (D) | 2017-03-24 | 2017-04-14 | BENDAMUSTINE + RITUXIMAB | N | N | 330011594 | BENDAMUSTINE + RITUXIMAB |
| 330002840 | 330001529 | 1.77 | 70 | Palliative (P) | 2017-07-26 | 2017-08-08 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 330011612 | CARBOPLATIN + PACLITAXEL |
| 330002841 | 330001530 | 1.6 | 68.1 | Curative (C) | null | 2014-07-12 | BENDAMUSTINE + RITUXIMAB | N | N | 330011615 | BENDAMUSTINE + RITUXIMAB |
| 330002842 | 330001531 | 1.75 | null | Adjuvant (A) | 2016-08-30 | 2016-08-30 | Bendamustine+Rituximab (1st Course) | N | N | 330011623 | BENDAMUSTINE + RITUXIMAB |
| 330002843 | 330001531 | 1.68 | 54.85 | Palliative (P) | 2013-11-11 | 2013-11-22 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330011623 | CARBOPLATIN + PACLITAXEL |
| 330002844 | 330001531 | 1.67 | 62.5 | Palliative (P) | 2015-05-12 | 2015-05-17 | Carboplatin AUC 2 - 5 | N | N | 330011623 | CARBOPLATIN |
| 330002845 | 330001531 | 1.64 | 47 | Palliative (P) | 2015-04-30 | 2015-05-20 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330011623 | CARBOPLATIN + PACLITAXEL |
| 330002846 | 330001531 | 1.8 | 100 | Disease modification (D) | 2017-08-16 | 2017-08-21 | Bendamustine+Rituximab (1st Course) | 02 | N | 330011623 | BENDAMUSTINE + RITUXIMAB |
| 330002847 | 330001531 | null | null | Palliative (P) | 2018-05-29 | 2018-05-31 | CARBOPLATIN + PACLITAXEL | null | null | 330011623 | CARBOPLATIN + PACLITAXEL |
| 330002848 | 330001531 | 1.76 | 108.2 | Palliative (P) | null | 2017-09-14 | Rituximab | N | N | 330011623 | RITUXIMAB |
| 330002849 | 330001532 | null | null | Curative (C) | 2013-01-08 | 2013-01-17 | Bendamustine+Rituximab (1st Course) | null | N | 330011640 | BENDAMUSTINE + RITUXIMAB |
| 330002850 | 330001532 | 1.59 | 56.2 | Disease modification (D) | 2017-03-11 | 2017-03-13 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330011640 | LIPOSOMAL DOXORUBICIN |
| 330002851 | 330001533 | 1.7 | 85.8 | Curative (C) | 2016-07-20 | 2016-07-20 | Rituximab | N | N | 330011646 | RITUXIMAB |
| 330002852 | 330006814 | 1.97 | 108.55 | Curative (C) | 2016-05-14 | 2016-05-28 | Rituximab | 02 | N | 330011649 | RITUXIMAB |
| 330002853 | 330001534 | 1.77 | null | Palliative (P) | 2014-09-14 | 2014-09-15 | CARBOPLATIN + ETOPOSIDE | N | N | 330011650 | CARBOPLATIN + ETOPOSIDE |
| 330002854 | 330001534 | 1.77 | 69.7 | Adjuvant (A) | 2017-11-05 | 2017-12-01 | Carboplatin + Etoposide IV 3 day | 02 | N | 330011650 | CARBOPLATIN + ETOPOSIDE |
| 330002855 | 330001535 | 1.71 | 58.5 | Disease modification (D) | 2015-02-13 | 2015-02-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330011654 | CARBOPLATIN + PACLITAXEL |
| 330002856 | 330001536 | null | null | Not known (9) | 2017-06-25 | 2017-07-12 | Carboplatin + Etoposide iv&po | N | Y | 330011658 | CARBOPLATIN + ETOPOSIDE |
| 330002857 | 330001537 | 1.85 | null | Disease modification (D) | 2017-09-22 | 2017-09-23 | Liposomal Doxorubicin (Caelyx) | 02 | null | 330011667 | LIPOSOMAL DOXORUBICIN |
| 330002858 | 330001537 | 1.72 | 63.6 | Neo-adjuvant (N) | 2016-07-10 | 2016-08-08 | Cisplatin + Doxorubicin | N | N | 330011667 | CISPLATIN + DOXORUBICIN |
| 330002859 | 330001538 | 1.64 | 85.8 | Adjuvant (A) | 2017-10-26 | 2017-11-11 | Carboplatin + Etoposide IV 3 day | 02 | N | 330011673 | CARBOPLATIN + ETOPOSIDE |
| 330002860 | 330001539 | 1.8 | 78.5 | Curative (C) | 2014-10-06 | 2014-10-06 | Carboplatin + Etoposide IV 3 day | N | N | 330011674 | CARBOPLATIN + ETOPOSIDE |
| 330002861 | 330001539 | 0.68 | 83 | Not known (9) | 2013-11-06 | 2013-11-06 | Carboplatin AUC 6 - 10 | N | N | 330011674 | CARBOPLATIN |
| 330002862 | 330001540 | null | 81.5 | Disease modification (D) | null | 2014-11-22 | Rituximab | null | null | 330011679 | RITUXIMAB |
| 330002863 | 330001541 | 1.75 | 93 | Not known (9) | 2015-05-20 | 2015-06-03 | Carboplatin AUC 2 - 5 | 02 | N | 330011681 | CARBOPLATIN |
| 330002864 | 330006818 | 1.66 | 66 | null | 2013-10-28 | 2013-10-28 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330011682 | CARBOPLATIN + PACLITAXEL |
| 330002865 | 330001542 | 1.61 | null | Curative (C) | 2014-12-14 | 2014-12-21 | Carboplatin + Etoposide IV 3 day | N | N | 330011683 | CARBOPLATIN + ETOPOSIDE |
| 330002866 | 330001542 | 1.59 | null | Not known (9) | 2015-10-15 | 2015-11-10 | CARBOPLATIN + PACLITAXEL | 2 | N | 330011683 | CARBOPLATIN + PACLITAXEL |
| 330002867 | 330001542 | 1.72 | 71.5 | null | 2013-11-11 | 2013-12-03 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011683 | CARBOPLATIN + PACLITAXEL |
| 330002868 | 330001542 | null | 91.3 | Palliative (P) | 2015-07-09 | 2015-07-09 | Carboplatin + Etoposide IV 3 day | N | null | 330011683 | CARBOPLATIN + ETOPOSIDE |
| 330002869 | 330001542 | 1.82 | 108.2 | Curative (C) | 2016-06-04 | 2016-06-09 | Carboplatin AUC 6 - 10 | 2 | N | 330011683 | CARBOPLATIN |
| 330002870 | 330001543 | 1.7 | 86.35 | Palliative (P) | 2016-02-25 | 2016-03-17 | Liposomal Doxorubicin (20mg/m2) | 02 | N | 330011689 | LIPOSOMAL DOXORUBICIN |
| 330002871 | 330001543 | 1.82 | 94.9 | Palliative (P) | 2015-09-19 | 2015-10-03 | CARBOPLATIN + ETOPOSIDE | N | N | 330011689 | CARBOPLATIN + ETOPOSIDE |